Brink's (BCO) Q1 2026 earnings review
Digital Growth Masks a Heavy M&A Toll on GAAP Margins
Brink's delivered a strong top-line quarter, with revenue growing 10% YoY to $1.37B, driven by a 15% organic surge in its high-margin AMS/DRS segment. However, it is a tale of two income statements. While management touts Stable Adjusted EBITDA margins (+10 bps YoY to 17.3%), GAAP net income plummeted 38% YoY. The culprit? An Accelerating wave of transformation and M&A costs ($38.9M this quarter) tied to the pending NCR Atleos acquisition. To digest this mega-deal by 2027, Brink's is Reversing its capital allocation strategy, halting stock buybacks to focus entirely on aggressive debt reduction.
🐂 Bull Case
The higher-margin AMS/DRS segment continues to post Mid-to-High Teens organic growth. It now represents 31% of the total revenue mix, proving the company's shift away from asset-heavy legacy transport.
Trailing twelve-month Free Cash Flow breached $500M for the first time, achieving an impressive 50% conversion rate from Adjusted EBITDA, giving Brink's the firepower needed to deleverage.
🐻 Bear Case
The gap between GAAP and Non-GAAP earnings is widening drastically. $38.9M in transformation and acquisition costs hit Q1, and these 'one-time' costs will likely persist every quarter until the Atleos deal closes in 2027.
With AMS/DRS growing 15% and total organic growth at 4.5%, the legacy Cash & Valuables Management (CVM) business is essentially flat, serving strictly as a slow-growth funding mechanism.
⚖️ Verdict: ⚪
Neutral. The operational execution in the digital segment is flawless, and the cash flow is excellent. However, pausing buybacks removes a major stock catalyst, and the heavy M&A integration costs make the current valuation entirely dependent on flawless execution of the 2027 Atleos integration.
Key Themes
AMS/DRS Remains the Unstoppable Growth Engine
Brink's technology-driven ATM Managed Services (AMS) and Digital Retail Solutions (DRS) segment delivered a Stable, high 15% organic growth rate in Q1. The segment now accounts for nearly a third of total revenue. By pushing tech solutions like the KAL ATM software, Brink's is successfully transitioning from a logistics vendor to a recurring-revenue tech partner.
Exploding 'One-Time' Adjustments Crush GAAP Margins
Management emphasizes an expanding Adjusted EBITDA margin of 17.3%, but this completely contradicts the actual GAAP performance. GAAP Operating Margin suffered a Reversing trend, dropping 160 bps YoY to 8.0%. The primary drag is $38.9M in NCR Atleos acquisition and transformation costs. Because the deal doesn't close until Q1 2027, investors should expect these heavy 'non-routine' costs to permanently depress GAAP earnings for the next 12-18 months.
Capital Allocation Reversing to Protect the Balance Sheet
After aggressively returning capital in 2025 ($154M in buybacks in the first 9 months), management is officially Reversing course. The share repurchase program is paused. Brink's must divert its massive cash flow entirely toward debt reduction to bring net leverage down to 2.3x by year-end 2026, preparing for the leverage spike that will accompany the Atleos acquisition.
Legacy CVM is a Laggard
The core Cash and Valuables Management (CVM) business is Decelerating into stagnation. With total organic growth at 4.5% and AMS/DRS booming at 15%, the math implies the remaining ~70% of the business is growing at barely 0-1%. The legacy cash transport segment is becoming purely a cash-cow laggard to fund digital ambitions.
Cash Flow Generation Accelerating
Trailing-twelve-month Free Cash Flow breached $502M for the first time in company history, up 40% YoY. Q1 Operating Cash Flow Reversing from a $60M outflow last year to a $28M inflow this quarter demonstrates structural improvements in the cash cycle and disciplined working capital management.
Macro Volatility and Highly Inflationary Drags
Macroeconomic headwinds continue to cause heavy noise. Highly inflationary accounting in Argentina and currency devaluation drove significant non-operating volatility. While management effectively stripped this out of Non-GAAP results, underlying macro instability in Latin America remains a drag on real USD cash generation.
Operational Leverage in North America and Europe
North America and Europe displayed Accelerating profitability. North America Adjusted EBITDA grew 16% on just 5% revenue growth (margin reaching 19.1%). Europe's turnaround was even starker: Adjusted EBITDA surged 35% on 15% revenue growth, proving the Brink's Business System productivity measures are taking root globally.
Other KPIs
Stable. Up 10% YoY. The 17.3% margin reflects strong pricing discipline and favorable revenue mix, offsetting the structural decline in legacy cash volumes.
Decelerating. Dropped from 2.8x at the end of FY24 and 3.06x in early FY25. The company is actively paying down debt to hit a target of ~2.3x by the end of 2026.
Guidance
Decelerating slightly. The midpoint of $1,400M implies approximately 7.6% YoY total growth (compared to Q2 2025 revenue of $1,301M). This represents a mild slowdown from Q1's 10% total growth rate, driven by a normalization in organic trends (guided 3-6%).
Stable. The $255M midpoint implies a 9.9% YoY growth rate over the $232M delivered in Q2 2025. Margin is expected to remain healthy at approximately 18.2%, continuing the trend of strong operational leverage.
Stable. Management reiterated the full-year framework for converting 40-45% of Adjusted EBITDA into Free Cash Flow, maintaining the strong capital generation needed to pay down debt.
Key Questions
Run-Rate of Transformation Costs
With nearly $39 million in transformation and NCR Atleos acquisition costs in Q1 alone, what is the expected quarterly run-rate for these cash outflows leading up to the Q1 2027 close?
CVM Segment Secular Decline
As AMS/DRS organically grows at 15%, the math suggests the legacy Cash and Valuables Management business is essentially flat. Is CVM permanently transitioning into a no-growth, cash-cow phase?
Contingencies for Paused Buybacks
You've paused share repurchases to deleverage for Atleos. If the regulatory approval process extends beyond Q1 2027, will you resume buybacks, or stockpile cash indefinitely?